Detalles de la búsqueda
1.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161271
2.
PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.
Gynecol Oncol
; 173: 98-105, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105063
3.
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse.
Int J Gynecol Cancer
; 33(4): 577-584, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36631150
4.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183733
5.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207609
6.
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Anal Chem
; 94(16): 6297-6303, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416669
7.
Factors associated with compliance to cervical cancer screening in France: The EDIFICE 6 survey.
Gynecol Oncol
; 160(1): 112-117, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158509
8.
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
Gynecol Oncol
; 163(1): 64-71, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34294414
9.
Knowledge of bladder cancer in the French population: results of the EDIFICE 6 survey.
Eur J Cancer Care (Engl)
; 30(3): e13392, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33336542
10.
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Br J Cancer
; 122(6): 759-765, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32001832
11.
Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 26(2): 356-365, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30539492
12.
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
Gynecol Oncol
; 155(2): 262-269, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31604666
13.
Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.
Curr Oncol Rep
; 20(Suppl 1): 14, 2018 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29508088
14.
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Gynecol Oncol
; 142(3): 452-7, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27401840
15.
Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma.
Int J Cancer
; 137(8): 1890-900, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25892415
16.
CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
Gynecol Oncol
; 135(3): 542-6, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25223808
17.
Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours.
BJU Int
; 113(4): 574-80, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23937547
18.
Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.
Int J Gynecol Cancer
; 24(9 Suppl 3): S48-54, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25341580
19.
Plasma-based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer.
Mol Oncol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287892
20.
Management of trophoblastic tumors : review of evidence, current practice, and future directions.
Expert Rev Anticancer Ther
; 23(7): 699-708, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198729